Recent Articles from GlobeNewswire

LIMERICK, Ireland, Aug. 06, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), (“Kneat” or the “Company”), the global leader in digital validation and quality process automation, today announced that the Ontario Superior Court of Justice (Commercial List) has issued a final order approving the previously announced plan of arrangement (the “Proposed Transaction”) whereby an affiliate of Thoma Bravo, L.P. (“Thoma Bravo”) will acquire all of the outstanding common shares of the Company (the “Shares”), other than any rollover shares.

EBENE, Mauritius, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Gold remains one of the world's most actively traded safe-haven assets, with prices continuing to respond rapidly to geopolitical developments, central bank policy decisions, inflation expectations and shifts in investor sentiment. Investors increasingly navigate markets that move around the clock, where PU Prime has introduced XAUUSD247, enabling clients to trade gold 24 hours a day, seven days a week on MT5.

MONTREAL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or “the Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, today announces its financial and operating results for the second quarter ended June 30, 2026.

Palm Beach, FL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Pinnacle Acquisition Corporation (the “Company”) announced today that it priced its initial public offering of 20,000,000 units at $10.00 per unit. The units will be listed on the New York Stock Exchange (the “NYSE”) and trade under the ticker symbol “PNAQ.U” beginning August 7, 2026. Each unit consists of one Class A ordinary share and one right entitling the holder thereof to receive one-eighth (1/8) of one Class A ordinary share upon the consummation of an initial business combination. The Class A ordinary shares and rights comprising the units are expected to begin separate trading no later than the 52nd day following this date. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on the NYSE under the symbols “PNAQ” and “PNAQ.RT,” respectively.

In-vitro studies confirmed that the Company’s revolutionary therapy successfully disguised liver cancer cells as virally infected cells and activated pre-existing human antiviral Killer T-cells

SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., (“BlossomHill Therapeutics”), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to develop innovative small molecule medicines for the treatment of cancer, today announced the pricing of its upsized initial public offering of 9,375,000 shares of common stock at a price to the public of $16.00 per share. The gross proceeds to BlossomHill Therapeutics from the offering, before deducting underwriting discounts and commissions and offering expenses payable by BlossomHill Therapeutics, are expected to be $150.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. In addition, BlossomHill Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 1,406,250 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being offered by BlossomHill Therapeutics.

THOUSAND OAKS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Latigo Biotherapeutics, Inc. (“Latigo”), a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines, today announced the pricing of its upsized initial public offering of 19,200,000 shares of common stock at a price to the public of $18.00 per share. All of the shares of common stock are being offered by Latigo. The gross proceeds to Latigo from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Latigo, are expected to be $345.6 million. In addition, the underwriters have a 30-day option to purchase up to an additional 2,880,000 shares of common stock at the public offering price, less underwriting discounts and commissions.

Second annual event at Renaissance Dallas Hotel will connect, empower, and elevate Hispanic professionals across the cleaning and facility solutions industries through bilingual education, leadership development, networking, and Visionario Gala

BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Dr. Barbara Weber, the Executive Chairman of the Board of Directors of Tango Therapeutics, will be stepping down in connection with other pursuits.

Lead program now in Phase 1 development

Management to host live webcast and investor Q&A on August 13 at 5:00 pm ET

Former JPMorgan Chase and Walgreens Communications Executive Heads Practice With Decades of Experience Navigating Major Corporate Transformations, Strategic Transactions, and Public Market Readiness

Berkadia climbs to No. 4 in Real Estate Alert’s Top Brokers of Multifamily Properties in the first half of 2026

CANTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (“DXL” or the “Company”) (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men’s clothing and shoes, today announced that Lionel Conacher, Chairman of the DXL Board of Directors, has been named Interim Chief Executive Officer, effective August 12, 2026. Mr. Conacher will continue in his role as Chairman of the DXL Board. Mr. Conacher’s appointment follows the previously announced retirement of Harvey Kanter, effective August 11, 2026. Mr. Kanter will also step down from the Board at that time.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Datavault AI (DVLT) To Contact Him Directly To Discuss Their Options

SOUTH BEND, Ind., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) (the “Company”) reported today its operating results for the quarter ended June 30, 2026.

SOUTH BEND, Ind., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) (the “Company”) today announced that its Board of Directors declared a cash dividend on its common stock in the amount of $0.17 per share (the “Dividend”). The Dividend will be payable in cash on September 30, 2026, to stockholders of record as of the close of business on September 16, 2026.

VANCOUVER, British Columbia, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTCIQ: ATCMF) announces its operating results for the three months ended June 30, 2026 from its El Roble mine. Production for the quarter totaled 2.08 million pounds of copper and 1,465 ounces of gold in concentrates.

Adjusted EBITDA of $92 million and Net Earnings of $1 million 

MONTREAL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. (“D-BOX” or the "Company") (TSX: DBO) today announced that it will release its first quarter financial results for the period ended June 30, 2026, after market close on August 11, 2026 (after 5:00 p.m. Eastern Time). A conference call to discuss the results will be held on August 13, 2026, at 8:30 a.m. Eastern Time.

Q2 2026 revenues were $9.7 million, down 3% from $10.1 million in Q2 2025. 

HOUSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ: MVST), (“Microvast” or the “Company”), a global leader in advanced battery technologies, will issue a press release reporting its consolidated financial results for the second quarter of 2026 after market close on Monday, August 10, 2026.

Declares Monthly Base Distributions of $0.09 Per Share for October, November and December 2026

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Alibaba (BABA) To Contact Him Directly To Discuss Their Options

Approval Offers New Hope for Patients with Anti-PD-1 Refractory Melanoma

June 30, 2026 Quarter Highlights:

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) --

ISTANBUL, Aug. 06, 2026 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish e-commerce platform (referred to herein as “Hepsiburada” or the “Company”), today announces its unaudited financial results for the second quarter ended June 30, 2026.

HERNDON, Va., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) today posted its 2026 second quarter financial results. Complete financial results are available on the company’s website at Navient.com/investors. The materials will also be available on a Form 8-K on the SEC’s website at www.sec.gov.

LONDON and NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced that the Compensation Committee of the Company’s Board of Directors approved equity awards under the Company’s 2026 Employment Inducement Award Plan to a new employee. The equity awards were granted as an inducement material to the new employee entering employment with MeiraGTx in accordance with Nasdaq Listing Rule 5635(c)(4).

Selected Highlights

Lasme-cel: Pivotal Phase 2 in r/r B-ALL (BALLI-01) 

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- DoubleVerify (“DV”) (NYSE: DV) today announced financial results for the second quarter ended June 30, 2026.

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) --

Second Quarter Net Sales of $152.5 millionSecond Quarter Net Income of $16.9 millionDiluted EPS of $0.73 for the QuarterTotal Debt Reduced by Approximately $30.8 million During the Quarter

July 2026 Revenue Increased 102% sequential July Over June to Approximately $640,000

Grew Quarterly Sales at Outdoor by 8.5%

Dallas, Texas, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $22.3 million, or $.78 per share, in the second quarter of 2026 compared to net income of $.9 million, or $.03 per share, in the second quarter of 2025. For the first six months of 2026, Valhi reported net income attributable to Valhi stockholders of $24.3 million, or $.85 per share, compared to $17.8 million, or $.62 per share, in the first six months of 2025. Net income attributable to Valhi stockholders increased in the second quarter of 2026 as compared to the same period of 2025 primarily due to higher operating results from the Chemicals Segment. Net income attributable to Valhi stockholders increased in the first six months of 2026 as compared to the same period of 2025 primarily due to improved operating results across all business segments.

DENVER, CO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Rank One Computing Corporation d/b/a ROC, (Nasdaq: ROC) (“ROC” or the “Company”), a U.S. leader in Vision AI, building unified biometric, video analytics, and decision intelligence solutions, today announced that it will release its financial results for the second quarter of 2026 after the market close on Thursday, August 13, 2026.

SANTA MONICA, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), an audience intelligence and media activation company trusted by global brands to reach and influence people who play video games across the digital landscape, announced today that the Company will post its second quarter 2026 financial results before market open on Friday, August 14, 2026. A webinar will be held the same day at 8:30 am Eastern Time to discuss the results and can be accessed using the below dial-in numbers or registration link.

FAIRPORT, N.Y., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Seneca Foods Corporation (NASDAQ: SENEA, SENEB) today announced financial results for the three months ended June 27, 2026.

AUDUBON, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the second quarter ended June 30, 2026.

CINCINNATI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- The E.W. Scripps Company (NASDAQ: SSP) delivered $490 million in revenue for the second quarter of 2026. Loss attributable to the shareholders of Scripps was $1.2 billion or $12.68 per share. A non-cash goodwill and other intangible assets impairment charge for the quarter accounted for $11.61 of the per-share loss.

PURCHASE, N.Y., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders (the “Company” or “Cognition”), today reported financial results for the second quarter ended June 30, 2026, and provided a business update.

- Q3 Sales increase 14% to $339 Million - Q3 GAAP EPS from Continuing Operations increases 31% to $1.26 - Q3 Adjusted EPS from Continuing Operations increases 38% to $2.20 -

Dallas, Texas, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE:  VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on September 24, 2026 to stockholders of record at the close of business on September 3, 2026.

CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended June 30, 2026 and updated it's full-year 2026 guidance.

– Operating expenses decline 16%, helping drive a 39% improvement in net loss –

Private Capital platform surpassed $500 million in assetsManaged Investment Solutions flows reached $350 million

— Online Growth Fuels Record Sales and Solid Profitability —

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating whether certain officers and directors of Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) breached their fiduciary duties to shareholders in connection with a $520 million loan transaction between the Company and its Executive Chairman, Robert W. Duggan.

Signs Agreement to Acquire a Vertically Integrated Fuel Supply and Distribution Platform

SAN FRANCISCO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and prevent disease, today announced that it and its wholly owned subsidiary, iRhythm Technologies, Inc., have entered into a definitive agreement to acquire Vital Connect, Inc. (“VitalConnect”), a privately held leader in wearable biosensor technology and ambulatory cardiac monitoring.

Exceeded Q2 2026 Outlook for Revenue and Adjusted EBITDA

LONG BEACH, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN) (“SkinHealth Systems” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2026 (“Q2 2026”).

-- Profitability: Delivered better-than-expected operating results driven by continued tight management of operating expenses --

Delivered Total and Net Investment Income of $37.0 million and $18.2 million, Respectively

Fiscal 2026 revenue increased 11%, the second consecutive year of double-digit growth

ZUG, Switzerland, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced results for the second quarter ended June 30, 2026, and provided an overview of the Company’s progress.

CINCINNATI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Mobile Infrastructure Corporation (Nasdaq: BEEP), (“Mobile”, “Mobile Infrastructure” or the “Company”), the nation’s only publicly traded owner of parking infrastructure, today announced that the board of directors (the “Board”) has received a preliminary, non-binding indication of interest (the “Proposal Letter”) from Bombe Asset Management, LLC (“Bombe”) to acquire 100% of the issued and outstanding shares of common stock of Mobile (the “Proposed Transaction”).

Growing demand for Rigetti’s quantum systems, progress on the technology roadmap, and strategic U.S. government support

LITTLE ROCK, Ark., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Westrock Coffee Company (Nasdaq: WEST) (“Westrock Coffee” or the “Company”) today reported financial results for the second quarter ended June 30, 2026.

Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com

Key Investment highlights:

Q2'26 revenue grew 13% YoY to $251.0 million, above the midpoint of our guidance range

First patients dosed in aleniglipron (oral small molecule GLP-1 receptor agonist) Phase 3 ACCOMPLISH program for chronic weight management

Selected zovegalisib plus atirmociclib as go-forward triplet regimen for 1L breast cancer; Phase 3 1L trial in endocrine-sensitive patients expected to initiate in early 2027, subject to regulatory feedback

Second quarter SaaS revenue of $98.5 million, representing 27% year-over-year growth, 26% on a constant currency basisSecond quarter Total revenue of $124.5 million, representing 22% year-over-year growth, 21% on a constant currency basisTotal ARR of $465.1 million, representing 27% year-over-year growth, 24% adjusted for FX

SOUTH SAN FRANCISCO, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today reported financial results and business highlights for the second quarter ended June 30, 2026.

Second Quarter 2026 Highlights

BOCA RATON, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (the "Company") (Nasdaq: NEWT) reports its financial and operating results for the three months ended June 30, 2026.

Steady revenue growth and adjusted EBITDA margin* expansion

SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2026.

VANCOUVER, British Columbia, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today reported financial results for the second quarter ended June 30, 2026 and provided a summary of recent business highlights. In light of the previously announced proposed acquisition of Theravance Biopharma, the Company has elected not to host a second quarter earnings conference call after release of its financial results.

Q2 2026 total product revenue of $118.1 million, reflecting 31% growth year-over-year